Aqua Medical Secures Series B Funding to Advance U.S. Pivotal Trial for Novel Through-the-Scope Type 2 Diabetes Procedure
Led by Relevance Ventures, the funding will support the completion of Aqua Medical’s ongoing U.S. RESTORE-1 pilot study evaluating its investigational PIMA procedure for Type 2 diabetes while funding operational preparations to initiate a planned U.S. pivotal trial. PLEASANTON, Calif., [September 24, 2026] — Aqua Medical, Inc., a clinical-stage medical technology company advancing Endoscopic Metabolic […]